High throughput proteomic strategies for identifying tumour-associated antigens

Cancer Letters

Volumn 249, Issue 1, 2007, Pages 110-119

  Gunawardana, C Geeth ^a,b   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

Author keywords

Protein microarray; SEREX; SERPA; Tumour associated antigens

Indexed keywords

COMPLEMENTARY DNA; TUMOR ANTIGEN;

BIOSENSOR; CANCER IMMUNOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOTHERAPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN MICROARRAY; PROTEOMICS; SEROLOGY; SHORT SURVEY;

EID: 33947277394     PISSN: 03043835     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.canlet.2007.01.002     Document Type: Review

References (35)

1. Canadian Cancer Statistics 2006. from http://www.cancer.ca/ccs/internet/standard/0,3182, 3172_14279_371283_langId-en,00.html, 2006.
2. Jemal A., Siegel R., Ward E., Murray T., Xu J., Smigal C., and Thun M.J. Cancer statistics (2006)
3. CA Cancer J. Clin. 56 (2006) 106-130
4. Baldwin R.W. Immunity to transplanted tumour: the effect of tumour extracts on the growth of homologous tumours in rats. Br. J. Cancer 9 (1955) 646-651
5. Baldwin R.W. Tumour-specific immunity against spontaneous rat tumours. Int. J. Cancer 1 (1966) 257-264
6. Baldwin R.W. Immunology of the cancer cell. Clin. Radiol. 18 (1967) 261-267
7. Baldwin R.W., and Embleton M.J. Demonstration by colony inhibition methods of cellular and humoral immune reactions to tumour-specific antigens associated with aminoazo-dye-induced rat hepatomas. Int. J. Cancer. 7 (1971) 17-25
8. Anderson K.S., and LaBaer J. The sentinel within: exploiting the immune system for cancer biomarkers. J. Proteome Res. 4 (2005) 1123-1133
9. Sahin U., Tureci O., Schmitt H., Cochlovius B., Johannes T., Schmits R., Stenner F., Luo G., Schobert I., and Pfreundschuh M. Human neoplasms elicit multiple specific immune responses in the autologous host. Proc. Natl. Acad. Sci. USA 92 (1995) 11810-11813
10. Chen Y.T., Scanlan M.J., Sahin U., Tureci O., Gure A.O., Tsang S., Williamson B., Stockert E., Pfreundschuh M., and Old L.J. A testicular antigen aberrantly expressed in human cancers detected by autologous antibody screening. Proc. Natl. Acad. Sci. USA 94 (1997) 1914-1918
11. Park S., Lim Y., Lee D., Cho B., Bang Y.J., Sung S., Kim H.Y., Kim D.K., Lee Y.S., Song Y., and Jeoung D.I. Identification and characterization of a novel cancer/testis antigen gene CAGE-1. Biochim. Biophys. Acta 1625 (2003) 173-182
12. Jager D., Stockert E., Gure A.O., Scanlan M.J., Karbach J., Jager E., Knuth A., Old L.J., and Chen Y.T. Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library. Cancer Res. 61 (2001) 2055-2061
13. Jager D., Stockert E., Scanlan M.J., Gure A.O., Jager E., Knuth A., Old L.J., and Chen Y.T. Cancer-testis antigens and ING1 tumor suppressor gene product are breast cancer antigens: characterization of tissue-specific ING1 transcripts and a homologue gene. Cancer Res. 59 (1999) 6197-6204
14. Fernandez Madrid F., Tang N., Alansari H., Karvonen R.L., and Tomkiel J.E. Improved approach to identify cancer-associated autoantigens. Autoimmun. Rev. 4 (2005) 230-235
15. Klade C.S., Voss T., Krystek E., Ahorn H., Zatloukal K., Pummer K., and Adolf G.R. Identification of tumor antigens in renal cell carcinoma by serological proteome analysis. Proteomics 1 (2001) 890-898
16. Gygi S.P., Corthals G.L., Zhang Y., Rochon Y., and Aebersold R. Evaluation of two-dimensional gel electrophoresis-based proteome analysis technology. Proc. Natl. Acad. Sci. USA 97 (2000) 9390-9395
17. Wang H., and Hanash S. Multi-dimensional liquid phase based separations in proteomics. J. Chromatogr. B. Analyt. Technol. Biomed. Life Sci. 787 (2003) 11-18
18. Imafuku Y., Omenn G.S., and Hanash S. Proteomics approaches to identify tumor antigen directed autoantibodies as cancer biomarkers. Dis. Markers 20 (2004) 149-153
19. Feng Y., Ke X., Ma R., Chen Y., Hu G., and Liu F. Parallel detection of autoantibodies with microarrays in rheumatoid diseases. Clin. Chem. 50 (2004) 416-422
20. Miller J.C., Zhou H., Kwekel J., Cavallo R., Burke J., Butler E.B., Teh B.S., and Haab B.B. Antibody microarray profiling of human prostate cancer sera: antibody screening and identification of potential biomarkers. Proteomics 3 (2003) 56-63
21. Qin S., Qiu W., Ehrlich J.R., Ferdinand A.S., Richie J.P., O'leary M.P., Lee M.L., and Liu B.C. Development of a "reverse capture autoantibody microarray for studies of antigen-autoantibody profiling. Proteomics 6 (2006) 3199-3209
22. Smith G.P. Filamentous fusion phage: novel expression vectors that display cloned antigens on the virion surface. Science 228 (1985) 1315-1317
23. Wang X., Yu J., Sreekumar A., Varambally S., Shen R., Giacherio D., Mehra R., Montie J.E., Pienta K.J., Sanda M.G., Kantoff P.W., Rubin M.A., Wei J.T., Ghosh D., and Chinnaiyan A.M. Autoantibody signatures in prostate cancer. N. Engl. J. Med. 353 (2005) 1224-1235
24. Qiu J., Madoz-Gurpide J., Misek D.E., Kuick R., Brenner D.E., Michailidis G., Haab B.B., Omenn G.S., and Hanash S. Development of natural protein microarrays for diagnosing cancer based on an antibody response to tumor antigens. J. Proteome Res. 3 (2004) 261-267
25. Nam M.J., Madoz-Gurpide J., Wang H., Lescure P., Schmalbach C.E., Zhao R., Misek D.E., Kuick R., Brenner D.E., and Hanash S.M. Molecular profiling of the immune response in colon cancer using protein microarrays: occurrence of autoantibodies to ubiquitin C-terminal hydrolase L3. Proteomics 3 (2003) 2108-2115
26. Angelopoulou K., Rosen B., Stratis M., Yu H., Solomou M., and Diamandis E.P. Circulating antibodies against p53 protein in patients with ovarian carcinoma. Correlation with clinicopathologic features and survival. Cancer 78 (1996) 2146-2152
27. Bradford T.J., Wang X., and Chinnaiyan A.M. Cancer immunomics: using autoantibody signatures in the early detection of prostate cancer. Urol. Oncol. 24 (2006) 237-242
28. Angelopoulou K., and Diamandis E.P. Detection of the TP53 tumour suppressor gene product and p53 auto-antibodies in the ascites of women with ovarian cancer. Eur. J. Cancer. 33 (1997) 115-121
29. Sandler B., Smirnoff P., Shani A., Idelevich E., Pfefferman R., Davidovich B., Zusman R., and Zusman I. The role of the soluble p53 antigen and its autoantibodies as markers for diagnosis of colon cancer: a comparative study. Int. J. Mol. Med. 1 (1998) 453-457
30. Tureci O., Mack U., Luxemburger U., Heinen H., Krummenauer F., Sester M., Sester U., Sybrecht G.W., and Sahin U. Humoral immune responses of lung cancer patients against tumor antigen NY-ESO-1. Cancer Lett. 236 (2006) 64-71
31. Stockert E., Jager E., Chen Y.T., Scanlan M.J., Gout I., Karbach J., Arand M., Knuth A., and Old L.J. A survey of the humoral immune response of cancer patients to a panel of human tumor antigens. J. Exp. Med. 187 (1998) 1349-1354
32. von Mensdorff-Pouilly S., Gourevitch M.M., Kenemans P., Verstraeten A.A., Litvinov S.V., van Kamp G.J., Meijer S., Vermorken J., and Hilgers J. Humoral immune response to polymorphic epithelial mucin (MUC-1) in patients with benign and malignant breast tumours. Eur. J. Cancer. 32A (1996) 1325-1331
33. Fishman P., Merimski O., Baharav E., and Shoenfeld Y. Autoantibodies to tyrosinase: the bridge between melanoma and vitiligo. Cancer 79 (1997) 1461-1464
34. Graham K.L., Vaysberg M., Kuo A., and Utz P.J. Autoantigen arrays for multiplex analysis of antibody isotypes. Proteomics 6 (2006) 5720-5724
35. Li C., Xiao Z., Chen Z., Zhang X., Li J., Wu X., Li X., Yi H., Li M., Zhu G., and Liang S. Proteome analysis of human lung squamous carcinoma. Proteomics 6 (2006) 547-558